We recently published that dietary fat reduction combined with IGF-1R antibody blockade resulted in decreased proliferation in prostate cancer xenografts and a reduction in serum insulin and TNF alpha levels without affecting final tumor weights [13]. The gene discussed is INS; the disease is neoplasm.